INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46m ago
HOUSE PTR5m ago
SEC 13F5m ago
ROBINHOOD CHAIN5m ago
Public company

ANNXAnnexon, Inc.

CIK 0001528115

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells3 / 1
Max Insider Score36
Connections5with evidence

ANNX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
LD
Love DouglasDirector, PRESIDENT AND CEO
ANNXAnnexon, Inc.
Open-market purchase
BUY$100K
26.1K sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Love DouglasDirector, PRESIDENT AND CEO · Sep 25, 2026
  • ← Insider ofevidence
    Cockroft Bettina M.Director · Jun 15, 2026
  • ← Insider ofevidence
    Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER · Feb 20, 2026
9
CM
Cockroft Bettina M.Director
ANNXAnnexon, Inc.
Grant or award
A
—
65.0K sh
Jun 11, 2026
Jun 15, 2026
traded Jun 11, 2026
+4d
SEC FORM 4

Evidence

19
CH
Carson William H.Director
ANNXAnnexon, Inc.
Open-market purchase · 10b5-1 plan
BUY$50K
8,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

5
AR
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
ANNXAnnexon, Inc.
Grant or award
A—
250.0K sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC FORM 4

Evidence

17
AR
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
ANNXAnnexon, Inc.
Grant or award
A—
62.5K sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC FORM 4

Evidence

21
AR
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
ANNXAnnexon, Inc.
Open-market sale
SELL$27K
5,290 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

29
CH
Carson William H.Director
ANNXAnnexon, Inc.
Open-market purchase · 10b5-1 plan
BUY$21K
4,115 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Carson William H.Director · Jan 2, 2026